Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Vecuronium Bromide, and what generic Vecuronium Bromide alternatives are available?

Vecuronium Bromide is a drug marketed by Sun Pharma Global, West-ward Pharms Int, Watson Labs, Mylan Labs Ltd, Hospira, Sagent Pharms, Teva Pharms Usa, and Gland Pharma Ltd. and is included in ten NDAs.

The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.

Summary for Tradename: VECURONIUM BROMIDE

Suppliers / Packagers: see list12
Bulk Api Vendors: see list47
Clinical Trials: see list115
Patent Applications: see list983
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VECURONIUM BROMIDE at DailyMed

Pharmacology for Tradename: VECURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
vecuronium bromide
INJECTABLE;INJECTION079001-001Jun 17, 2009APRXNoYes► Subscribe► Subscribe
Gland Pharma Ltd
vecuronium bromide
INJECTABLE;INJECTION205390-001May 26, 2016APRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
vecuronium bromide
INJECTABLE;INJECTION090243-001May 11, 2010APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
vecuronium bromide
INJECTABLE;INJECTION075218-002Aug 23, 1999DISCNNoNo► Subscribe► Subscribe
vecuronium bromide
INJECTABLE;INJECTION075164-001Oct 21, 1999APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus